| Literature DB >> 30951022 |
Charles Schlappi1, Joshua D Bernstock2,3, Wilson Ricketts2, Garrett A Nix2, Claudette Poole4, Jeffrey Lebensburger1, Gregory K Friedman1.
Abstract
Roseomonas gilardii is a Gram-negative coccobacillus identified in immunocompromised pediatric patients. A 5-year-old male with a history of HbSβ thalassemia status postsurgical splenectomy presented to the emergency department with fever. Blood cultures grew R. gilardii at 63 hours, but the patient had been discharged home at 48 hours. The patient was readmitted for repeat cultures and initiated on meropenem for 10 days as Roseomonas spp. are often resistant to third generation cephalosporins. R. gilardii is a rare cause of bacteremia in immunocompromised patients. Clinicians should consider Roseomonas in slow growing Gram-negative rod bacteremias, and consider meropenem as empiric coverage.Entities:
Mesh:
Year: 2020 PMID: 30951022 PMCID: PMC7724631 DOI: 10.1097/MPH.0000000000001476
Source DB: PubMed Journal: J Pediatr Hematol Oncol ISSN: 1077-4114 Impact factor: 1.289